156 related articles for article (PubMed ID: 30756327)
21. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
[TBL] [Abstract][Full Text] [Related]
22. Factors affecting successful breast conservation for ductal carcinoma in situ.
Dillon MF; Mc Dermott EW; O'Doherty A; Quinn CM; Hill AD; O'Higgins N
Ann Surg Oncol; 2007 May; 14(5):1618-28. PubMed ID: 17443388
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of percutaneous vacuum assisted intact specimen breast biopsy device for ultrasound visualized breast lesions: Upstage rates and long term follow-up for high risk lesions and DCIS.
Graham CL
Breast; 2017 Jun; 33():38-43. PubMed ID: 28279887
[TBL] [Abstract][Full Text] [Related]
24. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
26. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
[TBL] [Abstract][Full Text] [Related]
27. Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland.
Tang SS; Kaptanis S; Haddow JB; Mondani G; Elsberger B; Tasoulis MK; Obondo C; Johns N; Ismail W; Syed A; Kissias P; Venn M; Sundaramoorthy S; Irwin G; Sami AS; Elfadl D; Baggaley A; Remoundos DD; Langlands F; Charalampoudis P; Barber Z; Hamilton-Burke WLS; Khan A; Sirianni C; Merker LAG; Saha S; Lane RA; Chopra S; Dupré S; Manning AT; St John ER; Musbahi A; Dlamini N; McArdle CL; Wright C; Murphy JO; Aggarwal R; Dordea M; Bosch K; Egbeare D; Osman H; Tayeh S; Razi F; Iqbal J; Ledwidge SFC; Albert V; Masannat Y
Eur J Cancer; 2017 Oct; 84():315-324. PubMed ID: 28865259
[TBL] [Abstract][Full Text] [Related]
28. The impact of field cancerization on the extent of duct carcinoma in situ (DCIS) in breast tissue after conservative excision.
Asioli S; Morandi L; Cavatorta C; Cucchi MC; Foschini MP
Eur J Surg Oncol; 2016 Dec; 42(12):1806-1813. PubMed ID: 27546014
[TBL] [Abstract][Full Text] [Related]
29. The safety of multiple re-excisions after lumpectomy for breast cancer.
Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
[TBL] [Abstract][Full Text] [Related]
30. Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
Grimm LJ; Ryser MD; Partridge AH; Thompson AM; Thomas JS; Wesseling J; Hwang ES
Ann Surg Oncol; 2017 Nov; 24(12):3534-3540. PubMed ID: 28795370
[TBL] [Abstract][Full Text] [Related]
31. Residual disease after re-excision lumpectomy for close margins.
Sabel MS; Rogers K; Griffith K; Jagsi R; Kleer CG; Diehl KA; Breslin TM; Cimmino VM; Chang AE; Newman LA
J Surg Oncol; 2009 Feb; 99(2):99-103. PubMed ID: 19065638
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
[TBL] [Abstract][Full Text] [Related]
34. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
35. Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Pilewskie M; Stempel M; Rosenfeld H; Eaton A; Van Zee KJ; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3487-3493. PubMed ID: 27172775
[TBL] [Abstract][Full Text] [Related]
36. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
37. Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgery.
Yu CC; Chiang KC; Kuo WL; Shen SC; Lo YF; Chen SC
Breast; 2013 Oct; 22(5):698-702. PubMed ID: 23333255
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
Houssami N; Ambrogetti D; Marinovich ML; Bianchi S; Macaskill P; Vezzosi V; Mamounas EP; Ciatto S
Ann Surg Oncol; 2011 May; 18(5):1364-71. PubMed ID: 21107741
[TBL] [Abstract][Full Text] [Related]
39. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.
van der Noordaa ME; Pengel KE; Groen E; van Werkhoven E; Rutgers EJ; Loo CE; Vogel W; Vrancken Peeters MJ
Eur J Surg Oncol; 2015 Apr; 41(4):553-8. PubMed ID: 25707349
[TBL] [Abstract][Full Text] [Related]
40. Breast segmentectomy with rotation mammoplasty as an oncoplastic approach to extensive ductal carcinoma in situ.
Szynglarewicz B; Maciejczyk A; Forgacz J; Matkowski R
World J Surg Oncol; 2016 Mar; 14():72. PubMed ID: 26956623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]